Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the average time taken is for eligible people at highest risk of becoming seriously ill with covid-19 to be offered antibody and antiviral treatments for use at home after having tested positive for covid-19 but not having been admitted to hospital.

Non-hospitalised individuals at highest risk from COVID-19 are potentially eligible for treatments via COVID Medicines Delivery Units. These treatments include antivirals and neutralising monoclonal antibodies (nMABs). In England, patients in this cohort have been treated within an average of 3.5 to four days from symptom onset. Oral antiviral treatments such as molnupiravir or Paxlovid are suitable to be taken at home. Other treatments, such as the intravenous antiviral remdesivir or the nMAB treatment sotrovimab, are administered intravenously within a clinical setting. Treatment times are generally faster for oral antivirals.